106 related articles for article (PubMed ID: 18646329)
21. Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.
Suárez-García I; Sobrino-Vegas P; Dalmau D; Rubio R; Iribarren JA; Blanco JR; Gutierrez F; Montero Alonso M; Bernal E; Vinuesa García D; Del Amo J;
Addiction; 2016 Jul; 111(7):1235-45. PubMed ID: 26890155
[TBL] [Abstract][Full Text] [Related]
22. Was the 1988 HIV epidemic among Bangkok's injecting drug users a common source outbreak?
Wright NH; Vanichseni S; Akarasewi P; Wasi C; Choopanya K
AIDS; 1994 Apr; 8(4):529-32. PubMed ID: 8011258
[TBL] [Abstract][Full Text] [Related]
23. HIV risk behaviors but absence of infection among drug users in detoxification centers outside Yunnan province, China, 1993.
Zheng X; Tian C; Zhang G; Li D; Liu X; Hu DJ; Weniger BG; Dondero TJ
AIDS; 1995 Aug; 9(8):959-63. PubMed ID: 7576334
[TBL] [Abstract][Full Text] [Related]
24. Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen Among Virally Suppressed Individuals.
Calkins KL; Lesko CR; Chander G; Moore RD; Lau B
J Acquir Immune Defic Syndr; 2018 Mar; 77(3):317-324. PubMed ID: 29210833
[TBL] [Abstract][Full Text] [Related]
25. Late HIV Testing in a Cohort of HIV-Infected Patients in Puerto Rico.
Tossas-Milligan KY; Hunter-Mellado RF; Mayor AM; Fernández-Santos DM; Dworkin MS
P R Health Sci J; 2015 Sep; 34(3):148-54. PubMed ID: 26356739
[TBL] [Abstract][Full Text] [Related]
26. Prospective effects of perceived risk of developing HIV/AIDS on risk behaviors among injection drug users in Puerto Rico.
Robles RR; Cancel LI; Colón HM; Matos TD; Freeman DH; Sahai H
Addiction; 1995 Aug; 90(8):1105-11. PubMed ID: 7549779
[TBL] [Abstract][Full Text] [Related]
27. Association between syphilis, antibodies to herpes simplex virus type 2, and recreational drug use and hepatitis B virus infection in the Women's Interagency HIV Study.
Tien PC; Kovacs A; Bacchetti P; French AL; Augenbraun M; Cole SR; Hessol N; Justman J;
Clin Infect Dis; 2004 Nov; 39(9):1363-70. PubMed ID: 15494914
[TBL] [Abstract][Full Text] [Related]
28. Human immunodeficiency virus (HIV) infection in parenteral drug users: evolution of the epidemic over 10 years. Valencian Epidemiology and Prevention of HIV Disease Study Group.
Hernández-Aguado I; Aviño MJ; Pérez-Hoyos S; González-Aracil J; Ruiz-Pérez I; Torrella A; García de la Hera M; Belda F; Fernández E; Santos C; Trullen J; Fenosa A
Int J Epidemiol; 1999 Apr; 28(2):335-40. PubMed ID: 10342700
[TBL] [Abstract][Full Text] [Related]
29. A comparison of the sociodemographic, risk-behavior, and substance-abuse profile of young vs older HIV-infected Puerto Rican patients.
Fernández DM; Gómez Mde L; Figueroa W; Velázquez M; Báez DV; Ríos-Olivares E; Hunter RF
Ethn Dis; 2005; 15(4 Suppl 5):S5-25-9. PubMed ID: 16315378
[TBL] [Abstract][Full Text] [Related]
30. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic.
Easterbrook PJ; Yu LM; Goetghebeur E; Boag F; McLean K; Gazzard B
AIDS; 2000 Mar; 14(5):561-71. PubMed ID: 10780719
[TBL] [Abstract][Full Text] [Related]
31. The HIV epidemic associated with injecting drug use in Europe: geographic and time trends.
Hamers FF; Batter V; Downs AM; Alix J; Cazein F; Brunet JB
AIDS; 1997 Sep; 11(11):1365-74. PubMed ID: 9302447
[TBL] [Abstract][Full Text] [Related]
32. Laboratory markers and the risk of developing HIV-1 disease among injecting drug users.
Alcabes P; Selwyn PA; Davenny K; Hartel D; Buono D; Schoenbaum EE; Klein RS; Friedland GH
AIDS; 1994 Jan; 8(1):107-15. PubMed ID: 7912083
[TBL] [Abstract][Full Text] [Related]
33. Injection Drug Use, Unemployment, and Severe Food Insecurity Among HIV-HCV Co-Infected Individuals: A Mediation Analysis.
McLinden T; Moodie EEM; Hamelin AM; Harper S; Walmsley SL; Paradis G; Aibibula W; Klein MB; Cox J
AIDS Behav; 2017 Dec; 21(12):3496-3505. PubMed ID: 28726043
[TBL] [Abstract][Full Text] [Related]
34. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.
Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I
Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418
[TBL] [Abstract][Full Text] [Related]
35. Distribution of naïve (CD45RA+) and memory (CD45RO+) T-cells in HIV-infected Puerto Rican population.
Roman M; Rodriguez JW; Pagán NO; Rios-Olivares E; Amill A; Hunter R
P R Health Sci J; 2002 Sep; 21(3):195-201. PubMed ID: 12243109
[TBL] [Abstract][Full Text] [Related]
36. The changing pattern of human immunodeficiency virus type 1 infection in intravenous drug users. Results of a six-year seroprevalence study in Palermo, Italy.
Romano N; Vitale F; Alesi DR; Bonura F; La Licata R; Intonazzo V; Dardanoni G; Mammina C
Am J Epidemiol; 1992 Jun; 135(11):1189-96. PubMed ID: 1626537
[TBL] [Abstract][Full Text] [Related]
37. Injecting drug use and HIV infection in southwest China.
Zheng X; Tian C; Choi KH; Zhang J; Cheng H; Yang X; Li D; Lin J; Qu S; Sun X
AIDS; 1994 Aug; 8(8):1141-7. PubMed ID: 7986413
[TBL] [Abstract][Full Text] [Related]
38. Sexual behaviour of women living with HIV/AIDS naïve for antiretroviral therapy: the ICONA-BEHEPI Study.
Aloisi MS; Serraino D; Girardi E; Lauria FN; D'Arminio Monforte A; Cargnel A; Bonazzi L; Petrosillo N; Abrescia N; Mazzotta F; Vullo V; Ferraro T; Suter F; Masi A; Rezza G; Ippolito G;
AIDS Care; 2000 Dec; 12(6):789-95. PubMed ID: 11177458
[TBL] [Abstract][Full Text] [Related]
39. Active injection drug-abuse offsets healthcare engagement in HIV-infected patients.
Liappis AP; Laake AM; Delman M
AIDS Behav; 2015 Jan; 19(1):81-4. PubMed ID: 24710959
[TBL] [Abstract][Full Text] [Related]
40. A Review of Factors Associated with Age of First Injection.
McLaughlin M; Amaya A; Klevens M; O'Cleirigh C; Batchelder A
J Psychoactive Drugs; 2020; 52(5):412-420. PubMed ID: 32795151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
